Lumexa Imaging (NASDAQ:LMRI) reported first-quarter results that management said were in line with expectations, as growth in advanced imaging modalities helped offset seasonal volume pressure and weather-related disruptions.
Chief Executive Officer Caitlin Zulla said the company “recovered our momentum” as volumes improved throughout March. She said Lumexa is focused this year on same-center growth, expanding its mix of advanced modalities, opening de novo centers, ramping newly opened centers, building strategic service lines and broadening its geographic footprint.
